您当前的位置：
首页 >
文章列表页 >
Efficacy of adjuvant 131I therapy for postoperative solitary cervical lymph node metastasis in differentiated thyroid cancer and its influencing factors
Article | 更新时间：2026-04-17

    • Efficacy of adjuvant 131I therapy for postoperative solitary cervical lymph node metastasis in differentiated thyroid cancer and its influencing factors

    • China Oncology   Vol. 36, Issue 1, Pages: 77-83(2026)

    • DOI：10.19401/j.cnki.1007-3639.2026.01.008    

      CLC： R736.1

    • Received：29 October 2025，

      Revised：2025-12-28，

      Published：30 January 2026

    移动端阅览

  • RUAN Yi, YUAN Hui, ZHENG Feng, et al. Efficacy of adjuvant 131I therapy for postoperative solitary cervical lymph node metastasis in differentiated thyroid cancer and its influencing factors[J]. China Oncology, 2026, 36(1): 77-83. DOI： 10.19401/j.cnki.1007-3639.2026.01.008.

  •  
  •  

0

Views

17

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Analysis of therapeutic response of iodine positive metastasis lymph nodes in differentiated thyroid cancer after 131I treatment
Advances in understanding the correlation between lymph node metastasis and immune regulation in breast cancer through spatiotemporal transcriptomic analysis
Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: progress in external beam radiotherapy (EBRT) for differentiated thyroid cancer
Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: progress in ultrasound, CT, MRI and ablation of thyroid nodules and differentiated thyroid cancer
Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: precision treatment guided by genotyping

Related Author

Xiaoran MEI
Fang FENG
Hui WANG
Zhixiao WEI
WANG Xiaowen
BI Zhao
LING Yuanchao
ZHENG Luming

Related Institution

Department of Nuclear Medical, Xinhua Hospital Affiliated To Shanghai Jiao Tong University School of Medicine
Department of Nuclear Medical, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region
The 960th Hospital of PLA
Department of Breast Cancer Center, Shandong First Medical University Affiliated Tumor Hospital (Shandong Provincial Institute of Cancer Prevention and Treatment, Shandong Cancer Hospital)
Shandong First Medical University (Shandong Provincial Academy of Medical Sciences)
0